SID26747459

ID: ALA1256575

Chembl Id: CHEMBL1256575

Max Phase: Preclinical

Molecular Formula: C8H18N2O3S

Molecular Weight: 222.31

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCS(=N)(=O)CCC(N)C(=O)O

Standard InChI:  InChI=1S/C8H18N2O3S/c1-2-3-5-14(10,13)6-4-7(9)8(11)12/h7,10H,2-6,9H2,1H3,(H,11,12)

Standard InChI Key:  KJQFBVYMGADDTQ-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA1256575

    ---

Associated Targets(Human)

LMNA Tbio Prelamin-A/C (36751 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDM4E Tchem Lysine-specific demethylase 4D-like (40243 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF-10A (2462 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BIRC5 Tchem Baculoviral IAP repeat-containing protein 5 (144 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BT-20 (503 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-453 (1139 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PPO2 Tyrosinase (3884 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SARS-CoV-2 (38078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leishmania infantum (5912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 222.31Molecular Weight (Monoisotopic): 222.1038AlogP: 0.64#Rotatable Bonds: 7
Polar Surface Area: 104.24Molecular Species: ZWITTERIONHBA: 4HBD: 3
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 2.18CX Basic pKa: 9.09CX LogP: -2.97CX LogD: -2.98
Aromatic Rings: Heavy Atoms: 14QED Weighted: 0.59Np Likeness Score: 0.35

References

1. PubChem BioAssay data set, 
2. PubChem BioAssay data set, 
3. PubChem BioAssay data set, 
4. Galván I, Wakamatsu K, Alonso-Alvarez C, Solano F..  (2014)  Buthionine sulfoximine diverts the melanogenesis pathway toward the production of more soluble and degradable pigments.,  24  (9): [PMID:24703231] [10.1016/j.bmcl.2014.03.031]
5. Ellen Van Damme.  (2021)  Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity,  [10.6019/CHEMBL4651402]
6. Hu S,Sechi M,Singh PK,Dai L,McCann S,Sun D,Ljungman M,Neamati N.  (2020)  A Novel Redox Modulator Induces a GPX4-Mediated Cell Death That Is Dependent on Iron and Reactive Oxygen Species.,  63  (17): [PMID:32809827] [10.1021/acs.jmedchem.0c01016]
7. Wani, Tasaduq Hussain, Chowdhury, Goutam, Chakrabarty, Anindita.  (2021)  Generation of reactive oxygen species is the primary mode of action and cause of survivin suppression by sepantronium bromide (YM155),  12  (4.0): [PMID:34046628] [10.1039/d0md00383b]
8. de Lucio H, Revuelto A, Carriles AA, de Castro S, García-González S, García-Soriano JC, Alcón-Calderón M, Sánchez-Murcia PA, Hermoso JA, Gago F, Camarasa MJ, Jiménez-Ruiz A, Velázquez S..  (2022)  Identification of 1,2,3-triazolium salt-based inhibitors of Leishmania infantum trypanothione disulfide reductase with enhanced antileishmanial potency in cellulo and increased selectivity.,  244  [PMID:36332553] [10.1016/j.ejmech.2022.114878]